- 1 hr ago DIY Skincare Ingredients: How To Safely Use Them
- 1 hr ago How To Deal With A Crying Baby? 10 Ways To Soothe A Crying Newborn
- 2 hrs ago Valentine’s Day 2023: Budget Friendly, Romantic Gift Ideas For Special Women In Your Life
- 3 hrs ago Brahma Temple At Pushkar In Rajasthan: History, Architecture, Legend, And Timings
- Movies After QUITTING Rupali Ganguly’s Anupamaa, THIS TV Star Bags A New Show
- Finance Pradhan Mantri Kaushal Vikas Yojana PMKVY- FM Announced PMKVY 4.0 to be Launched Within the Next 3 Years
- News How PAN will be used as common ID for businesses
- Technology Samsung Galaxy M14 5G Renders, Color Options Leaked: India Launch Imminent
- Sports Tottenham nanager Antonio Conte is set to take a break from football after Surgery
- Education GATE 2023: Exam will be held on Feburary 4; Check Details Here
- Automobiles 2023 KTM 390 Adventure Revealed - Gets Spoked Wheels & Tubed Tyres
- Travel Amazing New Restaurants in Bangalore to visit this year
Homegrown pharma major Cipla Ltd and its partner Drugs for Neglected Diseases initiative (DNDi) on Tuesday announced the launch of a 4-in-1 antiretroviral treatment for children living with HIV in South Africa.
South African Health Products Regulatory Authority (SAHPRA) has approved the sweet-tasting, heat-stable and '4-in-1' fixed-dose combination of four antiretroviral (ARV) treatments composed of abacavir, lamivudine, lopinavir, and ritonavir that is specifically designed for infants and young children with HIV, Cipla said in a regulatory filing.
This combination treatment has been developed by Cipla and not-for-profit DNDi, it added. The new formulation does not require refrigeration. It has a sweet taste and is easy to administer to infants and children of different weights and ages, a major improvement for both children and their caregivers over previously available formulations, the company said.
"This approval has come at an important time when so many children are suffering from HIV at such a young age. We will continue in our endeavour to enable access to life-saving solutions for all," Cipla Managing Director and Global CEO Umang Vohra said.
DNDi Head of HIV Irene Mukui said it is highly significant that this first regulatory approval of the 4-in-1 formulation is from a country that has a high burden of HIV among children.
"SAHPRA's accelerated review is notable and encouraging for other high-burden countries, and we acknowledge this show of commitment by the South African authorities. Now, it is our hope that all the necessary steps will be taken - first in South Africa and then in other countries - to ensure the broadest possible access to this optimal formulation for young children who need it," Mukui added.
Until recently, Cipla said the only WHO-recommended lopinavir-based treatment available for babies and very young children in South Africa consisted of a syrup that contained 40 per cent alcohol and required refrigeration.
Caregivers struggled to give this bitter-tasting formulation to young children, leading to poor adherence. Caregivers without refrigeration had a very difficult time storing the formulations - sometimes burying them in the ground to keep them cold, it added.
South Africa has 2.38 lakh children under the age of 15 living with HIV - the highest in the world, the company said.
- disorders cureWorld AIDS Day 2022: Can Kissing An HIV Positive Person Cause An HIV Infection?
- wellnessHIV Positive Patients In Haryana To Get Free Health Facilities Like Lab And Radiological Tests
- disorders cureNew Study Signals The Development Of Unique Genetic Treatment For HIV
- disorders cureOver 17 Lakh People Contracted HIV In India In Last 10 Years By Unprotected Sex: RTI Reply
- disorders cureFirst Woman Reported Cured Of HIV After Stem Cell Transplant, Know Details
- wellnessWorld AIDS Day 2021: How To Take Care Of HIV Positive Family Member Or If You Are An HIV Patient
- diabetesWorld AIDS Day 2021: Diabetes In People With HIV - Risk Factors, Complications And Treatments
- disorders cureWomen With Advanced HIV Carried COVID-19 Virus For 216 Days, Says New Study
- disorders cureWorld AIDS Vaccine Day 2021: HIV Vaccine Myths And Facts
- disorders cureSevere Complications Of HIV/AIDS
- basicsWorld Aids Day 2020: Diagnosis, Treatments And Management Of HIV Infection During Pregnancy
- disorders cureWorld AIDS Day: Common HIV Symptoms In Women You Shouldn’t Ignore